Navigation Links
Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
Date:8/5/2009

- Program Focuses on Expanding Pipeline of Drugs For People with Type 1 Diabetes -

NEW YORK, Aug. 5 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation said today that it has entered into a novel collaborative research agreement with the Genomics Institute of the Novartis Research Foundation (GNF) to create a diabetes drug discovery and development platform. The four-year program is one of the largest and most comprehensive collaborations in the 40 year history of JDRF, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research.

"This agreement with GNF opens exciting new avenues for JDRF to speed the translation of basic research into drugs and treatments for type 1 diabetes," said Alan J. Lewis, PhD, President and Chief Executive Officer of JDRF. "By creating this highly interactive collaboration with a world class organization with demonstrated expertise in discovering and developing innovative therapeutics for medical needs, we are looking to expand both the targets and the realm of possible treatments that can benefit people living with diabetes."

Based in San Diego, GNF was founded in 1999. Funded by the Novartis Research Foundation, its mission is to develop and apply innovative technologies to the discovery of new biologic processes and new or improved therapeutics for people. With a team of 550 scientists and associates, it has an impressive track record of success in translational research, and has contributed significantly to Novartis' pipeline of therapeutic candidates.

The partnership between JDRF and GNF aims to deliver a succession of drug candidates to the clinic over the next four years. The initial focus will be on pancreatic beta cell regeneration and survival, to restore beta cell function in diabetes. The program builds on current JDRF funding
'/>"/>

SOURCE Juvenile Diabetes Research Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
2. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
3. Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis
4. Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala
5. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
6. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
7. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
8. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
11. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014  Nektar Therapeutics (Nasdaq: NKTR ) ... June 30, 2014 on Thursday, July 31, 2014, after the ... and chief executive officer, will host a conference call to ... p.m. Pacific Time (PT). The press release ... be accessed through a link that is posted on the ...
(Date:7/22/2014)... July 22, 2014 Cumberland Pharmaceuticals Inc. (NASDAQ: ... 2014 financial results after the market closes on Tuesday, ... webcast will be held on Tuesday, August 5, 2014, ... To participate in the call, please dial ... A rebroadcast of the teleconference will be available for ...
(Date:7/22/2014)... 22, 2014 Research and Markets ... Market by Equipment, by Reagent, by Application - Global ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals ... is one of the most important and widely used ... application segment of the cell culture market in 2013. ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
... Permanente leads the nation among all reporting commercial health ... conclusions were based on information in the 2010 National ... Kaiser Permanente received top marks for: ... Appropriate treatment for children with upper respiratory infection ...
... 11 More than 170 industry experts and thought ... executive workshops at AdvaMed 2010: The MedTech Conference ... fourth year, this annual medical technology industry developed and ... and around the world.   "This conference ...
Cached Medicine Technology:Kaiser Permanente Leads the Nation in 12 Quality Measures 2Kaiser Permanente Leads the Nation in 12 Quality Measures 3Medical Technology, Funding & Government Experts Address Business, Investment, Reimbursement, Compliance, Innovation, Regulatory and Legal Issues at AdvaMed 2010 2Medical Technology, Funding & Government Experts Address Business, Investment, Reimbursement, Compliance, Innovation, Regulatory and Legal Issues at AdvaMed 2010 3
(Date:7/23/2014)... --- Controlling pain during childbirth and post delivery may ... M.D., a Northwestern Medicine perinatal psychiatrist, in a July ... , Wisner,s editorial is based on a new Chinese ... epidural anesthesia during a vaginal delivery had a much ... have the epidural. , "Maximizing pain control in labor ...
(Date:7/22/2014)... Kansas City, MO (PRWEB) July 22, 2014 ... cheap Sporting Kansas City vs. Manchester City tickets at ... match will take place on Wednesday, July 23rd. Tickets ... up to game time. Ticket Down can be reached ... City vs. Manchester City are authentic and covered by Ticket ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 As ... products for consumers to buy can now reduce or ... News company has released its cosmetic buying guide to ... eyes at http://cherrynews.com/best-nourishing-eye-serum . , This guide is ... suffer from the different under eye circles that can ...
(Date:7/22/2014)... July 22, 2014 DocbookMD , ... of deploying one of the largest physician-centric mobile communication ... MHMD ) in Houston. , Created by Austin-based physicians, ... DocbookMD application will be embedded into MHMD’s Accountable Care ... for the best technology to put this capability at ...
(Date:7/22/2014)... Beach, FL (PRWEB) July 22, 2014 ... that they are now an authorized Daikin comfort pro ... and install Daikin indoor heating and cooling system equipment. ... each one is thoroughly reviewed before being approved. , ... an innovator in the Split System Air Conditioning Market. ...
Breaking Medicine News(10 mins):Health News:Controlling childbirth pain tied to lower depression risk 2Health News:Sporting Kansas City vs. Manchester City Tickets: Ticket Down Has Slashed Ticket Prices for Manchester City vs. Sporting Kansas City on July 23rd 2Health News:Remove Dark Circles Under Eyes: New Cosmetic Buying Guide Released Online for Men and Women 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 2Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 3Health News:Memorial Hermann Physician Network Launches Physician Mobile Communication Solution Throughout Houston 4Health News:Air Conditioning & Heating Inc. Now an Authorized Daikin Comfort Pro Dealer 2
... Toy Puppies to the Obama Daughters , , ... President-Elect Obama,s first promise: to get a family dog. But ... kept the new first-dad from making a decision. So, in ... donating 2 "asthma & allergy friendly" toy puppies to the Obama ...
... with imaging exam results may enable a more meticulous ... as a more personal and empathetic approach, according to ... the Radiological Society of North America (RSNA). , ... being and not as an anonymous case study," said ...
... the connection between second-hand smoke and coronary heart disease ... such passive smoking, exposures have been reduced. In an ... American Journal of Preventive Medicine , researchers from ... and Columbia University have recalibrated the CHD Policy Model ...
... Ensign Group, Inc.,(Nasdaq: ENSG ) announced that ... successfully graduated from the Centers for Medicare and,Medicaid Services, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , ... Laurie House, Director of Nursing at Pocatello Care,& Rehabilitation ...
... the face of one of the most,severe economic downturns ... of,Directors has approved an investment of up to a ... Employee pension plans, which are,often heavily invested in stocks ... nation,s worsening economy. Although conservatively,invested, the Sutter Health Retirement ...
... of higher mortality and lower surgery rates in women ... may be related to the complexity of evaluating the ... Mayo Clinic study published this month in the ... affects approximately 150 million people worldwide and often requires ...
Cached Medicine News:Health News:Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise 2Health News:Patient photos spur radiologist empathy and eye for detail 2Health News:The Ensign Group Successfully Graduates Second Nursing Home From CMS Special Focus Program 2Health News:The Ensign Group Successfully Graduates Second Nursing Home From CMS Special Focus Program 3Health News:Sutter Health Invests Hundreds of Millions in Employee Pension 2Health News:Women with mitral valve prolapse are treated less aggressively than men and may be at high risk 2
... patient ID verification and laboratory specimen labeling system ... the phlebotomist or nurse, the identity of the ... verification is made, a bar coded sample ID ... unique design simplifies and eliminates the interface problems ...
... Horizon Admin-Rx is a bar-code medication administration ... medication administration process with bar-code technology. Caregivers ... handheld or laptop device to verify that ... at the right time in the right ...
... MedPoint™, a Medication Administration Control ... positive assurance that they are administering ... When used with a bar coded ... MedPoint extends the benefits of the ...
... When it comes to medication administration, ... afford to make. The solution is the ... a highly-scalable bar-coded medication administration system, suitable ... also be used stand-alone, networked, or as ...
Medicine Products: